{
    "eid": "2-s2.0-85020919651",
    "title": "A pilot randomized trial on safety and efficacy of a novel topical combined inhibitor of janus kinase 1/3 and spleen tyrosine kinase for GVHD-associated ocular surface disease",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "Ophthalmology",
            "@code": "2731"
        }
    ],
    "keywords": [
        "Dry eye disease",
        "GVHD",
        "Janus kinase",
        "Ocular surface disease",
        "Spleen tyrosine kinase"
    ],
    "authors": [
        "Ahmad Kheirkhah"
    ],
    "citedby-count": 29,
    "ref-count": 34,
    "ref-list": [
        "National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report",
        "Ocular graft-versus-host disease: A review",
        "Ocular graft-versus-host disease",
        "Ocular graft versus host disease following allogeneic stem cell transplantation: A review of current knowledge and recommendations",
        "Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease",
        "The use of topical cyclosporin A in ocular graft-versus-host-disease",
        "Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD",
        "A new modality for immunosuppression: Targeting the JAK/STAT pathway",
        "Janus kinase-3 (JAK3) inhibition: A novel immunosuppressive option for allogeneic transplantation",
        "Targeting syk in autoimmune rheumatic diseases",
        "Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: Will promise meet expectations?",
        "Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: Results from a phase 1/2 trial",
        "Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease",
        "Effects of topical Janus Kinase inhibition on ocular surface inflammation and immunity",
        "International chronic ocular graft-vs-host-disease (GVHD) consensus group: Proposed diagnostic criteria for chronic GVHD (Part I)",
        "Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases",
        "The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis",
        "The Syk protein tyrosine kinase is essential for Fc\u03b3/receptor signaling in macrophages and neutrophils",
        "Therapeutic targeting of Syk in autoimmune diabetes",
        "Anti-inflammatory effect of topical administration of tofacitinib on corneal inflammation",
        "Modulation of graft-versus-host disease: Role of regulatory T lymphocytes",
        "Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib",
        "Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib",
        "Ruxolitinib in steroid refractory graft-vs.-host disease: A case report",
        "Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels",
        "Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface",
        "Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation",
        "Syk-coupled C-type lectins in immunity",
        "Mincle is an ITAM-coupled activating receptor that senses damaged cells",
        "Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease",
        "Methodologies to diagnose and monitor dry eye disease: Report of the diagnostic methodology subcommittee of the international Dry Eye Workshop (2007)",
        "In Vivo confocal microscopy in dry eye disease and related conditions",
        "In vivo confocal microscopy in dry eye disease associated with chronic graft-versus-host disease",
        "Corneal nerves in health and disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "San Francisco",
            "affilname": "Rigel Pharmaceuticals Inc.",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Boston",
            "affilname": "Harvard Medical School",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}